Candriam S.C.A. Harpoon Therapeutics, Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.54 - $8.08 $59,751 - $136,382	-16,879 Reduced 2.08%	792,689 $3.94 Million
Q4 2021 Feb 10, 2022	BUY	$5.69 - $7.83 $1.82 Million - $2.51 Million	320,054 Added 65.38%	809,568 $6.11 Million
Q2 2021 Jul 20, 2021	BUY	$13.81 - $23.25 $6.76 Million - $11.4 Million	489,488 Added 1882646.12%	489,514 $6.79 Million
Q1 2021 Apr 29, 2021	BUY	$17.65 - $24.16 $458 - $628	26 New	26 $1,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.